OBJECTIVES: To determine if measures reflecting chronic occupational lead exposure are associated with performance on neuropsychological tests. METHOD: 467 Canadian male lead smelter workers (mean (SD) age 43.4 (11.00) years, education 9.8 (3.18) years, years of employment 17.7 (7.43), and current blood lead concentration (B-Pb) 27.5 (8.4) micrograms dl-1) were given a neuropsychological screening battery. Time weighted average (TWA) and time integrated blood levels (IBL) were developed from B-Pb records obtained through regular medical monitoring (mean (range) TWA 40.1 (4.0-66.4) micrograms dl-1, mean IBL 765.2 (0.6-1625.7) micrograms-y dl-1). 14 neuropsychological variables were included in three multivariate analyses of covariance, with each exposure variable as the grouping variable (high, medium, and low) and age, education, score on a measure of depressive symptoms, and self reported alcohol use as the covariates. Groups did not differ in history of neurological conditions. RESULTS: Neither the B-Pb, TWA, nor IBL was significant by multivariate analyses of covariance (MANCOVA). When years of employment, a suppressor variable, was included as a covariate, IBL exposure groups differed significantly on digit symbol, logical memory, Purdue dominant hand, and trails A and B. CONCLUSIONS: A dose-effect relation was found between cumulative exposure (IBL) and neuropsychological performance at a time when current B-Pb concentrations were low and showed no association with performance.
OBJECTIVES: To determine if measures reflecting chronic occupational lead exposure are associated with performance on neuropsychological tests. METHOD: 467 Canadian male lead smelter workers (mean (SD) age 43.4 (11.00) years, education 9.8 (3.18) years, years of employment 17.7 (7.43), and current blood lead concentration (B-Pb) 27.5 (8.4) micrograms dl-1) were given a neuropsychological screening battery. Time weighted average (TWA) and time integrated blood levels (IBL) were developed from B-Pb records obtained through regular medical monitoring (mean (range) TWA 40.1 (4.0-66.4) micrograms dl-1, mean IBL 765.2 (0.6-1625.7) micrograms-y dl-1). 14 neuropsychological variables were included in three multivariate analyses of covariance, with each exposure variable as the grouping variable (high, medium, and low) and age, education, score on a measure of depressive symptoms, and self reported alcohol use as the covariates. Groups did not differ in history of neurological conditions. RESULTS: Neither the B-Pb, TWA, nor IBL was significant by multivariate analyses of covariance (MANCOVA). When years of employment, a suppressor variable, was included as a covariate, IBL exposure groups differed significantly on digit symbol, logical memory, Purdue dominant hand, and trails A and B. CONCLUSIONS: A dose-effect relation was found between cumulative exposure (IBL) and neuropsychological performance at a time when current B-Pb concentrations were low and showed no association with performance.
Authors: P Campara; F D'Andrea; R Micciolo; C Savonitto; M Tansella; C Zimmermann-Tansella Journal: Int Arch Occup Environ Health Date: 1984 Impact factor: 3.015
Authors: H Hänninen; A Aitio; T Kovala; R Luukkonen; E Matikainen; T Mannelin; J Erkkilä; V Riihimäki Journal: Occup Environ Med Date: 1998-03 Impact factor: 4.402
Authors: Rachel Grashow; Mark W Miller; Ann McKinney; Linda H Nie; David Sparrow; Howard Hu; Marc G Weisskopf Journal: Neurotoxicol Teratol Date: 2013-04-17 Impact factor: 3.763
Authors: Margit L Bleecker; D Patrick Ford; Christopher G Vaughan; Karen N Lindgren; Michael J Tiburzi; Karin Scheetz Walsh Journal: Environ Health Perspect Date: 2005-12 Impact factor: 9.031
Authors: Marc G Weisskopf; Howard Hu; Robert V Mulkern; Roberta White; Antonio Aro; Steve Oliveira; Robert O Wright Journal: Environ Health Perspect Date: 2004-04 Impact factor: 9.031